Johnson DW - Search Results

1

Variation in Peritoneal Dialysis Time on Therapy by Country: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study.

Lambie M, Zhao J, McCullough K, Davies SJ, Kawanishi H, Johnson DW, Sloand JA, Sanabria M, Kanjanabuch T, Kim YL, Shen JI, Pisoni RL, Robinson BM, Perl J; PDOPPS Steering Committee. Lambie M, et al. Among authors: johnson dw. Clin J Am Soc Nephrol. 2022 Jun;17(6):861-871. doi: 10.2215/CJN.16341221. Clin J Am Soc Nephrol. 2022. PMID: 35641246 Free PMC article.

2

Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis.

Hawley CM, Wall DR, Johnson DW, Campbell SB, Griffin AD, Rigby RJ, Petrie JJ. Hawley CM, et al. Among authors: johnson dw. Am J Kidney Dis. 1995 Oct;26(4):658-61. doi: 10.1016/0272-6386(95)90605-3. Am J Kidney Dis. 1995. PMID: 7573023

3

The role of DEXA bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patients.

Johnson DW, McIntyre HD, Brown A, Freeman J, Rigby RJ. Johnson DW, et al. Perit Dial Int. 1996 Jan-Feb;16(1):34-40. Perit Dial Int. 1996. PMID: 8616170

4

Is obesity a favorable prognostic factor in peritoneal dialysis patients?

Johnson DW, Herzig KA, Purdie DM, Chang W, Brown AM, Rigby RJ, Campbell SB, Nicol DL, Hawley CM. Johnson DW, et al. Perit Dial Int. 2000 Nov-Dec;20(6):715-21. Perit Dial Int. 2000. PMID: 11216565

5

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

Herzig KA, Purdie DM, Chang W, Brown AM, Hawley CM, Campbell SB, Sturtevant JM, Isbel NM, Nicol DL, Johnson DW. Herzig KA, et al. Among authors: johnson dw. J Am Soc Nephrol. 2001 Apr;12(4):814-821. doi: 10.1681/ASN.V124814. J Am Soc Nephrol. 2001. PMID: 11274243

6

Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload.

Johnson DW, Arndt M, O'Shea A, Watt R, Hamilton J, Vincent K. Johnson DW, et al. BMC Nephrol. 2001 Dec 3;2:2. doi: 10.1186/1471-2369-2-2. BMC Nephrol. 2001. PMID: 11737871 Free PMC article.

7

Predictors of decline of residual renal function in new peritoneal dialysis patients.

Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Hollett P. Johnson DW, et al. Perit Dial Int. 2003 May-Jun;23(3):276-83. Perit Dial Int. 2003. PMID: 12938830

8

Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients.

Rumpsfeld M, McDonald SP, Purdie DM, Collins J, Johnson DW. Rumpsfeld M, et al. Among authors: johnson dw. Am J Kidney Dis. 2004 Mar;43(3):492-501. doi: 10.1053/j.ajkd.2003.11.010. Am J Kidney Dis. 2004. PMID: 14981608

9

Recommendations for the use of icodextrin in peritoneal dialysis patients.

Johnson DW, Agar J, Collins J, Disney A, Harris DC, Ibels L, Irish A, Saltissi D, Suranyi M. Johnson DW, et al. Nephrology (Carlton). 2003 Feb;8(1):1-7. doi: 10.1046/j.1440-1797.2003.00117.x. Nephrology (Carlton). 2003. PMID: 15012742 Review.

10

Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations.

McDonald SP, Collins JF, Rumpsfeld M, Johnson DW. McDonald SP, et al. Among authors: johnson dw. Perit Dial Int. 2004 Jul-Aug;24(4):340-6. Perit Dial Int. 2004. PMID: 15335147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,702 results

Search Page

Filters